Skip to content

Clinical trials

Hypoparathyroidism trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Country / region: Germany Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20181
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Ascendis Pharma Bone Diseases A/S1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Shire1
Takeda1
University Hospital Augsburg1
University of Wuerzburg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism8
Parathyroid Diseases4
Endocrine System Diseases3
Hypocalcemia2
Calcium Metabolism Disorders1
Hypercalciuria1
Metabolic Diseases1
Muscular Diseases1
Musculoskeletal Abnormalities1
Musculoskeletal Diseases1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.